Exchange: NYSE·Updated 07:30 PM EDT
ANRO logo

ANRO Alto Neuroscience Inc.

$35.55
$0.85
(2.33%)
Today
Closed $35.55
$0.45
(1.27%)
After Hours
Reported EarningsAug 12
Mkt Cap$1.4B
Vol269,947.00

About ANRO

Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of psychiatric drugs. Its pipeline is composed of five clinical-stage assets which initially target depressive disorder and schizophrenia population. The company was founded by Amit Etkin, Dan Segal, and Wei Wu on March 25, 2019 and is headquartered in Mountain View, CA.
34

Bearish Sentiment

How do you feel about ANRO?

Advertisement|Remove ads.